Comparing two heart PET scan tracers
Part of Heart & circulation clinical trials.
This study compares two types of radioactive tracers used during heart PET scans to see if one is better at detecting blocked arteries. Participation involves receiving one of the tracers during your routine scan and may help improve heart disease diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a heart PET scan using a radioactive tracer called rubidium-82.
- You are 18 years of age or older.
- You have never had a heart attack.
- You have never had a procedure to open blocked heart arteries (such as angioplasty, stent, or bypass surgery).
- You have never had a heart transplant.
- You are not pregnant or breastfeeding.
- You have normal kidney function (creatinine level below 1.4 mg/dL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a specialized heart imaging test (PET/MPI) changes during the start of chemotherapy for cancer patients. It may help researchers understand whether this monitoring approach detects heart strain early and keeps patients safer during treatment.
This study compares a new dye (99mTc-4BOH) with an existing one to see which better shows blockages in heart arteries. If you have chest pain and a confirmed blockage, this trial may help improve detection of coronary artery disease.
This study compares two types of heart scans to see which one better finds blockages in the arteries of people with chest discomfort or shortness of breath when active. You will have both a special CT scan and a PET/CT scan to check the health of your heart arteries.
This trial compares two heart imaging tests (SPECT and coronary CTA) to see if a newer method gives a clearer picture of blood flow. If you have been referred for one of these tests, you may be able to help by also having the other test done at no extra risk.
This trial uses a heart scan (PET/CT) to better estimate blood flow in people with long-term coronary artery disease. It aims to help doctors choose the best treatment strategy and decide who may need more invasive testing or procedures.
This trial studies a heart scan medicine (99mTc-ECDG) to help evaluate coronary artery disease, a condition caused by narrowed heart arteries. It compares how well the scan works and looks at safety while you undergo standard heart stress imaging.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.